IRCT20160208026446N2已完成3 期
The Impact of Myo- inositol supplementation to prevent gestational diabetes in overweight pregnant women
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- Female
入选标准
- •Conscious written consent
- •Pregnant women with singleton pregnancy
- •Age above 18 years old
- •Gestational age 14 weeks
- •Pr-pregnancy BMI>= 25 and less than 30 kg / m 2
- •Fasting glucose less than 92 mg / dL or Random glucose less than 200 mg / dL
- •No chronic diseases such as diabetes, high blood pressure and cardiovascular disease
- •Non-smoking and alcohol
排除标准
- •The death experience of one of the first-degree relatives during pregnancy
- •Treatment with corticosteroids during pregnancy
研究者
相似试验
尚未招募
3 期
The effect of myo-inositol supplementation on NAFLDIRCT20190724044322N2Tabriz University of Medical Sciences44
已完成
3 期
The effect of myo-inositol supplementation on NAFLDnon-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20100209003320N22Tabriz University of Medical Sciences50
已完成
3 期
The impact of Myo-inositol supplementation with sleep hygiene education on sleep quality in pregnant womeIRCT20160208026446N3Babol University of Medical Sciences60
已完成
3 期
The effect of myoinositol supplementation on the prevention of gestational diabetes mellitusGestational diabetes mellitus (GDM).O24.4Gestational diabetes mellitusIRCT20120826010664N4Tehran University of Medical Sciences276
已完成
不适用
MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with Polycystic Ovary Syndrome: a multicentre double-blind randomised controlled trialNL-OMON52766Erasmus MC, Universitair Medisch Centrum Rotterdam464